Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Clinical trial NCT01213030 · COMPLETED

Trial details

NCT number: NCT01213030
Sponsor: Siemens Molecular Imaging
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Lung Cancer Liver Cancer

Start date: 2009-06-01
Primary completion: 2010-01-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.